Global Allergies Clinical Trials Review, H2, 2018 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 22, 2019--The “Allergies Global Clinical Trials Review, H2, 2018” clinical trials has been added to ResearchAndMarkets.com’s offering.
″ Allergies Global Clinical Trials Review, H2, 2018″ provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Reasons to Buy
Key Topics Covered:
For more information about this clinical trials report visit https://www.researchandmarkets.com/research/grcj56/global_allergies?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190222005158/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Clinical Trials,Allergy Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/22/2019 05:18 AM/DISC: 02/22/2019 05:18 AM